Finance

Lists
Why is 543828 up 3.17%?
Dive Deeper
543828:BOM
Sudarshan Pharma Industries Ltd
₹38.71
+3.17%
(+1.19) 1D
Oct 12, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 543828...
Open
₹37.98
High
₹38.71
Low
₹36.60
Mkt. cap
9.85B
Avg. vol.
425.60K
Volume
24.00K
P/E ratio
37.31
52-wk high
₹42.79
52-wk low
₹18.50
EPS
₹1.04
No. of employees
64
Open
₹37.98
High
₹38.71
Low
₹36.60
Mkt. cap
9.85B
Avg. vol.
425.60K
Volume
24.00K
P/E ratio
37.31
52-wk high
₹42.79
52-wk low
₹18.50
EPS
₹1.04
No. of employees
64
News stories
From web sources and news partners
About Sudarshan Pharma Industries Ltd
CEO-
Employees64
Founded2008
Headquarters-
SectorSpeciality chemicals
Last report
Aug 12, 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
1.74B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.69B
1.68B
2.21B
1.74B
Cost of goods sold
1.52B
1.48B
1.90B
1.50B
Cost of revenue
1.52B
1.48B
1.90B
1.50B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.78M
19.74M
33.01M
20.68M
Operating expense
82.51M
102.47M
106.15M
101.78M
Total operating expenses
1.61B
1.58B
2.01B
1.60B
Operating income
83.02M
99.60M
200.65M
144.93M
Other non operating income
18.63M
15.18M
-49.24M
12.20M
EBT including unusual items
42.28M
51.98M
157.04M
75.05M
EBT excluding unusual items
42.28M
51.98M
146.84M
75.05M
Income tax expense
3.56M
10.50M
43.12M
18.96M
Effective tax rate
8.41%
20.20%
27.46%
25.26%
Other operating expenses
55.72M
73.62M
62.22M
67.03M
Net income
41.83M
43.57M
107.26M
58.55M
Net profit margin
2.48%
2.59%
4.86%
3.36%
Earnings per share
-
-
-
-
Interest and investment income
-
-
20.21M
-
Interest expense
-59.38M
-62.79M
-46.82M
-82.07M
Net interest expenses
-59.38M
-62.79M
-26.61M
-82.07M
Depreciation and amortization charges
9.01M
9.11M
10.93M
14.06M
EBITDA
91.95M
102.17M
206.78M
154.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps